AMRC Ameresco | $18.61 -4.3% | 4/17/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Ameresco (NYSE:AMRC) on 4/17/2024 |
BLZE Backblaze | $9.12 +0.1% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $13.00 | Low | View details for Oppenheimer rating of Backblaze (NASDAQ:BLZE) on 4/17/2024 |
BAC Bank of America | $35.22 +1.6% | 4/17/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $45.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 4/17/2024 |
FSLR First Solar | $178.01 +2.8% | 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $269.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 4/17/2024 |
MS Morgan Stanley | $90.08 +1.1% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $101.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 4/17/2024 |
PANW Palo Alto Networks | $277.33 +0.8% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $305.00 -> $330.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 4/17/2024 |
|
QMCO Quantum | $0.41
| 4/17/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Quantum (NASDAQ:QMCO) on 4/17/2024 |
TWLO Twilio | $58.73 -0.7% | 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $75.00 | Low | View details for Oppenheimer rating of Twilio (NYSE:TWLO) on 4/17/2024 |
VIRX Viracta Therapeutics | $0.94 +32.3% | 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $13.00 | Low | View details for Oppenheimer rating of Viracta Therapeutics (NASDAQ:VIRX) on 4/17/2024 |
OBDE Blue Owl Capital Co. III | $15.07 -0.2% | 4/17/2024 | Initiated by | Oppenheimer | - | Outperform | $16.00 | Low | View details for Oppenheimer rating of Blue Owl Capital Co. III (NYSE:OBDE) on 4/17/2024 |
SKIL Skillsoft | $5.78 +6.1% | 4/16/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Skillsoft (NASDAQ:SKIL) on 4/16/2024 |
AGCO AGCO | $116.24 -0.7% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $153.00 -> $154.00 | Low | View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 4/16/2024 |
CNHI CNH Industrial | $12.35 -1.6% | 4/16/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of CNH Industrial (NYSE:CNHI) on 4/16/2024 |
CTVA Corteva | $53.53 +0.4% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $62.00 -> $67.00 | Low | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 4/16/2024 |
GS The Goldman Sachs Group | $403.91 +1.8% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $446.00 -> $479.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 4/16/2024 |
AVTX Avalo Therapeutics | $13.62 -14.6% | 4/16/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | | Low | View details for Oppenheimer rating of Avalo Therapeutics (NASDAQ:AVTX) on 4/16/2024 |
C Citigroup | $58.17 +2.0% | 4/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $88.00 -> $87.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 4/15/2024 |
EL Estée Lauder Companies | $138.07 +0.8% | 4/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Estée Lauder Companies (NYSE:EL) on 4/15/2024 |
JPM JPMorgan Chase & Co. | $179.96 -0.5% | 4/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $219.00 -> $217.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 4/15/2024 |
VRTX Vertex Pharmaceuticals | $393.10 -0.3% | 4/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $500.00 | Low | View details for Oppenheimer rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/15/2024 |
VERU Veru | $1.16 -7.2% | 4/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $5.00 | Low | View details for Oppenheimer rating of Veru (NASDAQ:VERU) on 4/15/2024 |
WFC Wells Fargo & Company | $57.18 +1.4% | 4/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Wells Fargo & Company (NYSE:WFC) on 4/15/2024 |
ZWS Zurn Elkay Water Solutions | $31.25 -1.5% | 4/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $37.00 | Low | View details for Oppenheimer rating of Zurn Elkay Water Solutions (NYSE:ZWS) on 4/12/2024 |
RVMD Revolution Medicines | $36.82 +1.6% | 4/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $43.00 -> $45.00 | Low | View details for Oppenheimer rating of Revolution Medicines (NASDAQ:RVMD) on 4/12/2024 |
SKYE Skye Bioscience | $17.36 +6.8% | 4/12/2024 | Initiated by | Oppenheimer | - | Outperform | $25.00 | Low | View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024 |
SKYE Skye Bioscience | $17.36 +6.8% | 4/12/2024 | Initiated by | Oppenheimer | - | Outperform | $25.00 | Low | View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024 |
QTTB Q32 Bio | $24.12 -3.5% | 4/11/2024 | Initiated by | Oppenheimer | - | Outperform | $50.00 | Low | View details for Oppenheimer rating of Q32 Bio (NASDAQ:QTTB) on 4/11/2024 |
LVRO Lavoro | $5.85
| 4/11/2024 | Initiated by | Oppenheimer | - | Outperform | $11.00 | Low | View details for Oppenheimer rating of Lavoro (NASDAQ:LVRO) on 4/11/2024 |
XPO XPO | $118.88 -2.8% | 4/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $130.00 -> $140.00 | Low | View details for Oppenheimer rating of XPO (NYSE:XPO) on 4/10/2024 |
KMX CarMax | $68.53 -1.8% | 4/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $105.00 | Low | View details for Oppenheimer rating of CarMax (NYSE:KMX) on 4/9/2024 |
CUE Cue Biopharma | $1.63 +8.7% | 4/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Cue Biopharma (NASDAQ:CUE) on 4/9/2024 |
EFX Equifax | $237.68 -0.4% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $273.00 -> $291.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 4/9/2024 |
IONS Ionis Pharmaceuticals | $40.91 -1.5% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $72.00 -> $75.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/9/2024 |
MSCI MSCI | $511.83 -0.3% | 4/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $659.00 -> $648.00 | Low | View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/9/2024 |
SEIC SEI Investments | $66.08 -0.5% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $77.00 -> $80.00 | Low | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 4/9/2024 |
TRU TransUnion | $69.61 -0.2% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $81.00 -> $90.00 | Low | View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 4/9/2024 |
APP AppLovin | $70.90 -2.0% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $85.00 | Low | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 4/8/2024 |
META Meta Platforms | $494.17 -1.1% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $525.00 -> $585.00 | Low | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 4/8/2024 |
GOOG Alphabet | $156.88 +0.6% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $172.00 -> $185.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOG) on 4/8/2024 |
HCI HCI Group | $109.95 -1.7% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $140.00 | Low | View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 4/5/2024 |
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad) Recently, Bitcoin smashed through its previous record high to hit $72,720.
It’s made many, many people very rich.
But one cryptocurrency expert and investing millionaire is declaring… >>Click here to find out what it is. |
THG The Hanover Insurance Group | $126.67 -1.9% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $150.00 | Low | View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 4/5/2024 |
SIGI Selective Insurance Group | $100.40 -1.5% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $120.00 | Low | View details for Oppenheimer rating of Selective Insurance Group (NASDAQ:SIGI) on 4/5/2024 |
LULU Lululemon Athletica | $344.86 +1.7% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $540.00 -> $445.00 | Low | View details for Oppenheimer rating of Lululemon Athletica (NASDAQ:LULU) on 4/5/2024 |
TRV Travelers Companies | $206.58 -7.4% | 4/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Travelers Companies (NYSE:TRV) on 4/5/2024 |
AXP American Express | $217.62 -0.3% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | Low | View details for Oppenheimer rating of American Express (NYSE:AXP) on 4/5/2024 |
ANGO AngioDynamics | $6.33 -2.8% | 4/5/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $12.00 | Low | View details for Oppenheimer rating of AngioDynamics (NASDAQ:ANGO) on 4/5/2024 |
VRT Vertiv | $81.88 -0.6% | 4/5/2024 | Initiated by | Oppenheimer | - | Outperform | $96.00 | Low | View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 4/5/2024 |
GENI Genius Sports | $5.27 +2.9% | 4/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Genius Sports (NYSE:GENI) on 4/4/2024 |
ULTA Ulta Beauty | $424.55 +0.1% | 4/4/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $600.00 -> $500.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 4/4/2024 |
COIN Coinbase Global | $213.78 -2.3% | 4/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $276.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 4/4/2024 |
AYI Acuity Brands | $248.47 -1.4% | 4/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $250.00 -> $315.00 | Low | View details for Oppenheimer rating of Acuity Brands (NYSE:AYI) on 4/4/2024 |
BMEA Biomea Fusion | $11.50 -3.8% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $70.00 | Low | View details for Oppenheimer rating of Biomea Fusion (NASDAQ:BMEA) on 4/3/2024 |
CMCSA Comcast | $38.99 -0.3% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $55.00 | Low | View details for Oppenheimer rating of Comcast (NASDAQ:CMCSA) on 4/3/2024 |
STRO Sutro Biopharma | $3.80 -3.6% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 4/3/2024 |
TMUS T-Mobile US | $160.09 +0.2% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $190.00 | Low | View details for Oppenheimer rating of T-Mobile US (NASDAQ:TMUS) on 4/3/2024 |
VZ Verizon Communications | $39.77
| 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 | Low | View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/3/2024 |
ALDX Aldeyra Therapeutics | $3.97 +2.6% | 4/3/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 4/3/2024 |
AIT Applied Industrial Technologies | $184.27 -1.9% | 4/2/2024 | Initiated by | Oppenheimer | - | Outperform | $235.00 | Low | View details for Oppenheimer rating of Applied Industrial Technologies (NYSE:AIT) on 4/2/2024 |
MVST Microvast | $0.52 -1.9% | 4/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $4.00 | Low | View details for Oppenheimer rating of Microvast (NASDAQ:MVST) on 4/2/2024 |
MCO Moody's | $375.41 +1.3% | 4/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $411.00 -> $424.00 | Low | View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 4/2/2024 |
SPGI S&P Global | $412.11 +0.9% | 4/2/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $480.00 | Low | View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 4/2/2024 |
TSLA Tesla | $155.45 -1.1% | 4/2/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 4/2/2024 |
JEF Jefferies Financial Group | $41.22 +0.4% | 4/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $52.00 -> $54.00 | Low | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 4/2/2024 |
ACHV Achieve Life Sciences | $4.57 +4.3% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $18.00 | Low | View details for Oppenheimer rating of Achieve Life Sciences (NASDAQ:ACHV) on 4/1/2024 |
CALC CalciMedica | $4.18 -3.7% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $14.00 | Low | View details for Oppenheimer rating of CalciMedica (NASDAQ:CALC) on 4/1/2024 |
CTAS Cintas | $668.51 +0.3% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Cintas (NASDAQ:CTAS) on 4/1/2024 |
DRRX DURECT | $0.88 +12.9% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $5.00 | Low | View details for Oppenheimer rating of DURECT (NASDAQ:DRRX) on 4/1/2024 |
KALA KALA BIO | $6.84 -0.1% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 | Low | View details for Oppenheimer rating of KALA BIO (NASDAQ:KALA) on 4/1/2024 |
NCNA NuCana | $3.97 +1.8% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $100.00 | Low | View details for Oppenheimer rating of NuCana (NASDAQ:NCNA) on 4/1/2024 |
CATX Perspective Therapeutics | 1.43 -2.1% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | 1.20 -> 1.50 | N/A | View details for Oppenheimer rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 4/1/2024 |
RH RH | $243.73 +0.2% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of RH (NYSE:RH) on 4/1/2024 |
SMTC Semtech | $32.86 -0.2% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Semtech (NASDAQ:SMTC) on 4/1/2024 |
ZURA Zura Bio | $3.13 +3.0% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $16.00 | Low | View details for Oppenheimer rating of Zura Bio (NASDAQ:ZURA) on 4/1/2024 |
SG Sweetgreen | $20.81 -1.7% | 4/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $34.00 | Low | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 4/1/2024 |
BRZE Braze | $39.53 -1.6% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $75.00 | Low | View details for Oppenheimer rating of Braze (NASDAQ:BRZE) on 3/28/2024 |
CLRB Cellectar Biosciences | $3.21 -3.0% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $12.00 | Low | View details for Oppenheimer rating of Cellectar Biosciences (NASDAQ:CLRB) on 3/28/2024 |
POOL Pool | $364.15 -1.6% | 3/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $407.00 -> $436.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 3/28/2024 |
RUM Rumble | $6.17 +2.0% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Rumble (NASDAQ:RUM) on 3/28/2024 |
SPXC SPX Technologies | $117.50 -1.1% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $124.00 -> $134.00 | Low | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 3/28/2024 |
CXM Sprinklr | $11.36 +0.2% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Sprinklr (NYSE:CXM) on 3/28/2024 |
VRNT Verint Systems | $29.13 -0.4% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Verint Systems (NASDAQ:VRNT) on 3/28/2024 |
IMVT Immunovant | $28.43 -6.5% | 3/28/2024 | Initiated by | Oppenheimer | - | Outperform | $50.00 | Low | View details for Oppenheimer rating of Immunovant (NASDAQ:IMVT) on 3/28/2024 |
XERS Xeris Biopharma | $1.78 -1.1% | 3/28/2024 | Initiated by | Oppenheimer | - | Outperform | $5.00 | Low | View details for Oppenheimer rating of Xeris Biopharma (NASDAQ:XERS) on 3/28/2024 |
CPRX Catalyst Pharmaceuticals | $16.00 +3.0% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $29.00 | Low | View details for Oppenheimer rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/27/2024 |
CGTX Cognition Therapeutics | $1.90 +0.5% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Cognition Therapeutics (NASDAQ:CGTX) on 3/27/2024 |
FRGE Forge Global | $1.82 +1.7% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $3.50 | Low | View details for Oppenheimer rating of Forge Global (NYSE:FRGE) on 3/27/2024 |
PRGS Progress Software | $50.59 -0.3% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $66.00 | Low | View details for Oppenheimer rating of Progress Software (NASDAQ:PRGS) on 3/27/2024 |
STRO Sutro Biopharma | $3.80 -3.6% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 3/27/2024 |
WPRT Westport Fuel Systems | $5.69 -0.2% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $19.00 | Low | View details for Oppenheimer rating of Westport Fuel Systems (NASDAQ:WPRT) on 3/27/2024 |
ADBE Adobe | $474.45 -0.4% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $660.00 | Low | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/27/2024 |
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad) Recently, Bitcoin smashed through its previous record high to hit $72,720.
It’s made many, many people very rich.
But one cryptocurrency expert and investing millionaire is declaring… >>Click here to find out what it is. |
UPS United Parcel Service | $142.25 -0.4% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $153.00 | Low | View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 3/27/2024 |
HCI HCI Group | $109.95 -1.7% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $140.00 | Low | View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 3/27/2024 |
VKTX Viking Therapeutics | $66.47 -2.2% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $116.00 -> $138.00 | Low | View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024 |
ALSN Allison Transmission | $79.78 -0.6% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $90.00 | Low | View details for Oppenheimer rating of Allison Transmission (NYSE:ALSN) on 3/26/2024 |
A Agilent Technologies | $134.55 -1.6% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $90.00 | Low | View details for Oppenheimer rating of Agilent Technologies (NYSE:A) on 3/26/2024 |
HARP Harpoon Therapeutics | $23.01
| 3/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | N/A | View details for Oppenheimer rating of Harpoon Therapeutics (NASDAQ:HARP) on 3/26/2024 |
ADUS Addus HomeCare | $96.62 -0.4% | 3/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $118.00 | Low | View details for Oppenheimer rating of Addus HomeCare (NASDAQ:ADUS) on 3/26/2024 |
DYN Dyne Therapeutics | $24.82 +0.8% | 3/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $47.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 3/26/2024 |
TH Target Hospitality | $10.64 +1.0% | 3/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $10.00 | Low | View details for Oppenheimer rating of Target Hospitality (NASDAQ:TH) on 3/25/2024 |
TSLA Tesla | $155.45 -1.1% | 3/25/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 3/25/2024 |
AMPX Amprius Technologies | $1.72 +1.8% | 3/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 | Low | View details for Oppenheimer rating of Amprius Technologies (NYSE:AMPX) on 3/22/2024 |
DRI Darden Restaurants | $152.97 -0.8% | 3/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $186.00 -> $182.00 | Low | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/22/2024 |
FDS FactSet Research Systems | $429.25 +0.5% | 3/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of FactSet Research Systems (NYSE:FDS) on 3/22/2024 |
FDX FedEx | $263.07 -0.7% | 3/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of FedEx (NYSE:FDX) on 3/22/2024 |
SHAK Shake Shack | $94.93 -1.7% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $108.00 -> $120.00 | Low | View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 3/22/2024 |
ROP Roper Technologies | $526.47 -0.1% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $580.00 -> $650.00 | Low | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 3/22/2024 |
KNF Knife River | $78.08 -0.9% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $75.00 -> $85.00 | Low | View details for Oppenheimer rating of Knife River (NYSE:KNF) on 3/22/2024 |
DMAC DiaMedica Therapeutics | $2.60 +9.7% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $6.00 | Low | View details for Oppenheimer rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 3/21/2024 |
TKR Timken | $83.85 -1.1% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $100.00 | Low | View details for Oppenheimer rating of Timken (NYSE:TKR) on 3/21/2024 |
TOL Toll Brothers | $113.42 -0.8% | 3/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $141.00 -> $157.00 | Low | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 3/21/2024 |
TRVI Trevi Therapeutics | $2.58 -3.0% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/21/2024 |
VOR Vor Biopharma | $1.73 +1.2% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $15.00 | Low | View details for Oppenheimer rating of Vor Biopharma (NYSE:VOR) on 3/21/2024 |
DKS DICK'S Sporting Goods | $196.93 -0.9% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $240.00 | Low | View details for Oppenheimer rating of DICK’S Sporting Goods (NYSE:DKS) on 3/20/2024 |
CSL Carlisle Companies | $368.76 -1.5% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $355.00 -> $405.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 3/20/2024 |
CRNX Crinetics Pharmaceuticals | $44.01 +1.2% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $55.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/20/2024 |
EQIX Equinix | $734.56 -1.0% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $875.00 -> $950.00 | Low | View details for Oppenheimer rating of Equinix (NASDAQ:EQIX) on 3/20/2024 |
NVDA NVIDIA | $840.35 -3.9% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $850.00 -> $1,100.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 3/20/2024 |
CRVS Corvus Pharmaceuticals | $1.36 -7.5% | 3/20/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $7.00 | Low | View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 3/20/2024 |
STEP StepStone Group | $35.37 +0.1% | 3/20/2024 | Initiated by | Oppenheimer | - | Outperform | $48.00 | Low | View details for Oppenheimer rating of StepStone Group (NASDAQ:STEP) on 3/20/2024 |
GRWG GrowGeneration | $2.14 -4.0% | 3/20/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of GrowGeneration (NASDAQ:GRWG) on 3/20/2024 |
C Citigroup | $58.17 +2.0% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $88.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 3/19/2024 |
CATX Perspective Therapeutics | 1.43 -2.1% | 3/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | 1.20 | N/A | View details for Oppenheimer rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 3/19/2024 |
GS The Goldman Sachs Group | $403.91 +1.8% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $506.00 -> $446.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 3/19/2024 |
JPM JPMorgan Chase & Co. | $179.96 -0.5% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $238.00 -> $219.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 3/19/2024 |
MS Morgan Stanley | $90.08 +1.1% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $109.00 -> $97.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 3/19/2024 |
USB U.S. Bancorp | $39.52 -3.6% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $61.00 -> $55.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 3/19/2024 |
WFC Wells Fargo & Company | $57.18 +1.4% | 3/19/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Wells Fargo & Company (NYSE:WFC) on 3/19/2024 |
ALPN Alpine Immune Sciences | $64.46 -0.1% | 3/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $33.00 -> $44.00 | Low | View details for Oppenheimer rating of Alpine Immune Sciences (NASDAQ:ALPN) on 3/19/2024 |
BAC Bank of America | $35.22 +1.6% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $46.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 3/19/2024 |
MOD Modine Manufacturing | $85.64 -5.2% | 3/19/2024 | Initiated by | Oppenheimer | - | Outperform | $105.00 | Low | View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 3/19/2024 |
CRBP Corbus Pharmaceuticals | $37.16 -9.6% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $51.00 -> $58.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 3/13/2024 |
CRNX Crinetics Pharmaceuticals | $44.01 +1.2% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $54.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/13/2024 |
DRI Darden Restaurants | $152.97 -0.8% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $186.00 | Low | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/13/2024 |
RRX Regal Rexnord | $159.53 -2.1% | 3/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $210.00 | Low | View details for Oppenheimer rating of Regal Rexnord (NYSE:RRX) on 3/13/2024 |
TRMB Trimble | $58.49 -0.7% | 3/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $72.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 3/14/2024 |
ADBE Adobe | $474.45 -0.4% | 3/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $660.00 | N/A | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/15/2024 |
LEN Lennar | $151.88 -0.5% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Lennar (NYSE:LEN) on 3/15/2024 |
MDGL Madrigal Pharmaceuticals | $228.34 -2.0% | 3/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $320.00 -> $375.00 | N/A | View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/15/2024 |
PTMN Portman Ridge Finance | $19.09 +0.6% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $20.00 | N/A | View details for Oppenheimer rating of Portman Ridge Finance (NASDAQ:PTMN) on 3/15/2024 |
SEIC SEI Investments | $66.08 -0.5% | 3/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $73.00 -> $77.00 | N/A | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 3/15/2024 |
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad) Recently, Bitcoin smashed through its previous record high to hit $72,720.
It’s made many, many people very rich.
But one cryptocurrency expert and investing millionaire is declaring… >>Click here to find out what it is. |
SMAR Smartsheet | $37.70 +3.1% | 3/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $55.00 | N/A | View details for Oppenheimer rating of Smartsheet (NYSE:SMAR) on 3/15/2024 |
URGN UroGen Pharma | $14.24 -1.7% | 3/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $35.00 -> $34.00 | N/A | View details for Oppenheimer rating of UroGen Pharma (NASDAQ:URGN) on 3/15/2024 |
WSM Williams-Sonoma | $282.23 -0.1% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Williams-Sonoma (NYSE:WSM) on 3/15/2024 |
EW Edwards Lifesciences | $87.24 -3.1% | 3/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $93.00 -> $100.00 | Low | View details for Oppenheimer rating of Edwards Lifesciences (NYSE:EW) on 3/18/2024 |
WCN Waste Connections | $164.72 +0.0% | 3/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $170.00 -> $180.00 | Low | View details for Oppenheimer rating of Waste Connections (NYSE:WCN) on 3/18/2024 |
VTYX Ventyx Biosciences | $4.38 -8.0% | 3/12/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $12.00 | Low | View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 3/12/2024 |
NFLX Netflix | $613.69 -0.6% | 3/11/2024 | Target Raised by | Oppenheimer | - | Outperform | $615.00 -> $725.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 3/11/2024 |
RWAY Runway Growth Finance | $12.58 +1.5% | 3/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Runway Growth Finance (NASDAQ:RWAY) on 3/8/2024 |
FIGS FIGS | $4.72 +1.3% | 3/8/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of FIGS (NYSE:FIGS) on 3/8/2024 |
FROG JFrog | $38.03 +1.4% | 3/7/2024 | Target Raised by | Oppenheimer | - | | $41.00 -> $48.00 | Low | View details for Oppenheimer rating of JFrog (NASDAQ:FROG) on 3/7/2024 |
EHAB Enhabit | $10.16 -0.8% | 3/7/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Enhabit (NYSE:EHAB) on 3/7/2024 |
JSPR Jasper Therapeutics | $23.82 -1.4% | 3/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $80.00 | Low | View details for Oppenheimer rating of Jasper Therapeutics (NASDAQ:JSPR) on 3/7/2024 |
MRNS Marinus Pharmaceuticals | $1.44 +20.0% | 3/7/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $9.00 | Low | View details for Oppenheimer rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 3/7/2024 |
PNR Pentair | $79.15 -1.1% | 3/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $82.00 -> $88.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 3/7/2024 |
RSI Rush Street Interactive | $6.33 -2.3% | 3/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $9.00 | Low | View details for Oppenheimer rating of Rush Street Interactive (NYSE:RSI) on 3/7/2024 |
WCC WESCO International | $152.48 -1.5% | 3/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $190.00 | N/A | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 3/7/2024 |
AOMR Angel Oak Mortgage REIT | $11.11 +2.3% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Angel Oak Mortgage REIT (NYSE:AOMR) on 3/6/2024 |
CNNE Cannae | $19.43 -1.2% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $27.00 | Low | View details for Oppenheimer rating of Cannae (NYSE:CNNE) on 3/6/2024 |
CHPT ChargePoint | $1.40 -6.7% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of ChargePoint (NYSE:CHPT) on 3/6/2024 |
BASE Couchbase | $23.83 -2.1% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $36.00 | Low | View details for Oppenheimer rating of Couchbase (NASDAQ:BASE) on 3/6/2024 |
CRWD CrowdStrike | $293.69 -1.8% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $355.00 | N/A | View details for Oppenheimer rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
DG Dollar General | $144.47 -0.4% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Dollar General (NYSE:DG) on 3/6/2024 |
HCP HashiCorp | $23.53 -0.5% | 3/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $34.00 | Low | View details for Oppenheimer rating of HashiCorp (NASDAQ:HCP) on 3/6/2024 |
IONS Ionis Pharmaceuticals | $40.91 -1.5% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $72.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 3/6/2024 |
MCRB Seres Therapeutics | $0.63 -1.6% | 3/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $9.00 -> $5.00 | Low | View details for Oppenheimer rating of Seres Therapeutics (NASDAQ:MCRB) on 3/6/2024 |
SCM Stellus Capital Investment | $13.49
| 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $14.00 | Low | View details for Oppenheimer rating of Stellus Capital Investment (NYSE:SCM) on 3/6/2024 |
SYF Synchrony Financial | $39.68 -0.6% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Synchrony Financial (NYSE:SYF) on 3/6/2024 |
AEVA Aeva Technologies | $2.98 -6.3% | 3/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Aeva Technologies (NYSE:AEVA) on 3/6/2024 |
ETNB 89bio | $9.16 -2.2% | 3/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of 89bio (NASDAQ:ETNB) on 3/5/2024 |
CODI Compass Diversified | $22.15 -1.1% | 3/5/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $21.00 -> $23.00 | Low | View details for Oppenheimer rating of Compass Diversified (NYSE:CODI) on 3/5/2024 |
COST Costco Wholesale | $715.19 -0.1% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $760.00 -> $805.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 3/5/2024 |
DYN Dyne Therapeutics | $24.82 +0.8% | 3/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $44.00 -> $47.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 3/5/2024 |
GE General Electric | $155.67 -0.7% | 3/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of General Electric (NYSE:GE) on 3/5/2024 |
IMRX Immuneering | $1.86 +1.1% | 3/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Immuneering (NASDAQ:IMRX) on 3/5/2024 |
GWW W.W. Grainger | $949.92 -0.7% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $1,075.00 -> $1,125.00 | Low | View details for Oppenheimer rating of W.W. Grainger (NYSE:GWW) on 3/5/2024 |
AVDL Avadel Pharmaceuticals | $17.99 -0.6% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $27.00 -> $29.00 | Low | View details for Oppenheimer rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 3/5/2024 |
DLTR Dollar Tree | $123.75 -0.2% | 3/4/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Dollar Tree (NASDAQ:DLTR) on 3/4/2024 |
CYTK Cytokinetics | $67.93 -1.6% | 3/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $107.00 | Low | View details for Oppenheimer rating of Cytokinetics (NASDAQ:CYTK) on 3/4/2024 |
LOW Lowe's Companies | $228.86 +0.2% | 3/4/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $230.00 | Low | View details for Oppenheimer rating of Lowe’s Companies (NYSE:LOW) on 3/4/2024 |
MDGL Madrigal Pharmaceuticals | $228.34 -2.0% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $320.00 | Low | View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/1/2024 |
SG Sweetgreen | $20.81 -1.7% | 3/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $17.00 | Low | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 3/1/2024 |
PNTG The Pennant Group | $20.01
| 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $22.00 | Low | View details for Oppenheimer rating of The Pennant Group (NASDAQ:PNTG) on 3/1/2024 |
ADSK Autodesk | $214.92 -5.8% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $265.00 -> $315.00 | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 3/1/2024 |
AVGO Broadcom | $1,282.63 -3.5% | 3/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $1,100.00 -> $1,500.00 | Low | View details for Oppenheimer rating of Broadcom (NASDAQ:AVGO) on 3/1/2024 |
ESTC Elastic | $94.61 -0.6% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $130.00 | Low | View details for Oppenheimer rating of Elastic (NYSE:ESTC) on 3/1/2024 |
HRZN Horizon Technology Finance | $11.20 -0.4% | 3/1/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Horizon Technology Finance (NASDAQ:HRZN) on 3/1/2024 |
EVH Evolent Health | $29.65 -1.7% | 3/1/2024 | Initiated by | Oppenheimer | - | Outperform | $45.00 | N/A | View details for Oppenheimer rating of Evolent Health (NYSE:EVH) on 3/1/2024 |
TBLA Taboola.com | $3.91 -0.8% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $6.00 | Low | View details for Oppenheimer rating of Taboola.com (NASDAQ:TBLA) on 2/29/2024 |
CHE Chemed | $604.17 -1.0% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $625.00 -> $650.00 | Low | View details for Oppenheimer rating of Chemed (NYSE:CHE) on 2/29/2024 |
CRNX Crinetics Pharmaceuticals | $44.01 +1.2% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $48.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 2/29/2024 |
The “Perfect Storm” for Gold (Ad) Gold has already reached all-time highs, and experts believe it's not slowing down any time soon.
In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! |
IMCR Immunocore | $54.58 +2.3% | 2/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $87.00 | Low | View details for Oppenheimer rating of Immunocore (NASDAQ:IMCR) on 2/29/2024 |
MRVL Marvell Technology | $66.48 -2.6% | 2/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $80.00 | Low | View details for Oppenheimer rating of Marvell Technology (NASDAQ:MRVL) on 2/29/2024 |
MMSI Merit Medical Systems | $71.51 -1.7% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $82.00 -> $87.00 | Low | View details for Oppenheimer rating of Merit Medical Systems (NASDAQ:MMSI) on 2/29/2024 |
OKTA Okta | $93.80 -1.3% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $125.00 | Low | View details for Oppenheimer rating of Okta (NASDAQ:OKTA) on 2/29/2024 |
RLJ RLJ Lodging Trust | $10.96 -2.4% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $15.00 | Low | View details for Oppenheimer rating of RLJ Lodging Trust (NYSE:RLJ) on 2/29/2024 |
RXST RxSight | $52.83 -2.7% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $61.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 2/29/2024 |
SHLS Shoals Technologies Group | $8.28 -0.8% | 2/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $42.00 -> $17.00 | Low | View details for Oppenheimer rating of Shoals Technologies Group (NASDAQ:SHLS) on 2/29/2024 |
SNOW Snowflake | $148.80 -1.0% | 2/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $240.00 -> $220.00 | Low | View details for Oppenheimer rating of Snowflake (NYSE:SNOW) on 2/29/2024 |
ARVN Arvinas | $33.45 +0.0% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $80.00 | Low | View details for Oppenheimer rating of Arvinas (NASDAQ:ARVN) on 2/28/2024 |
CLVT Clarivate | $6.91 +1.8% | 2/28/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Clarivate (NYSE:CLVT) on 2/28/2024 |
COMP Compass | $3.34 -3.2% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $6.00 | Low | View details for Oppenheimer rating of Compass (NYSE:COMP) on 2/28/2024 |
FSLR First Solar | $178.01 +2.8% | 2/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $268.00 -> $269.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 2/28/2024 |
IAS Integral Ad Science | $9.37 -1.7% | 2/28/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $20.00 | Low | View details for Oppenheimer rating of Integral Ad Science (NASDAQ:IAS) on 2/28/2024 |
QUIK QuickLogic | $12.48 -1.8% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $16.00 | Low | View details for Oppenheimer rating of QuickLogic (NASDAQ:QUIK) on 2/28/2024 |
RSG Republic Services | $188.95 +0.8% | 2/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $182.00 -> $195.00 | Low | View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 2/28/2024 |
TARS Tarsus Pharmaceuticals | $34.42 -1.4% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $59.00 | Low | View details for Oppenheimer rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 2/28/2024 |
VKTX Viking Therapeutics | $66.47 -2.2% | 2/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $116.00 | Low | View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 2/28/2024 |
WMT Walmart | $59.65 -0.3% | 2/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $67.00 | Low | View details for Oppenheimer rating of Walmart (NYSE:WMT) on 2/26/2024 |
CARG CarGurus | $21.22 -1.7% | 2/27/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $30.00 | Low | View details for Oppenheimer rating of CarGurus (NASDAQ:CARG) on 2/27/2024 |
DAWN Day One Biopharmaceuticals | $14.85 +1.6% | 2/27/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 2/27/2024 |
FATE Fate Therapeutics | $5.27 -2.0% | 2/27/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Fate Therapeutics (NASDAQ:FATE) on 2/27/2024 |
TMDX TransMedics Group | $87.86 -5.8% | 2/27/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $92.00 -> $105.00 | Low | View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 2/27/2024 |
IONS Ionis Pharmaceuticals | $40.91 -1.5% | 2/26/2024 | Reiterated by | Oppenheimer | - | Outperform | $63.00 -> $65.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 2/26/2024 |
MAIN Main Street Capital | $46.96 +0.4% | 2/26/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $41.00 -> $43.00 | Low | View details for Oppenheimer rating of Main Street Capital (NYSE:MAIN) on 2/26/2024 |
POOL Pool | $364.15 -1.6% | 2/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $370.00 -> $407.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 2/26/2024 |
SONY Sony Group | $81.61 -1.6% | 2/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $108.00 | Low | View details for Oppenheimer rating of Sony Group (NYSE:SONY) on 2/26/2024 |
TGT Target | $164.47 +0.7% | 2/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $160.00 -> $170.00 | Low | View details for Oppenheimer rating of Target (NYSE:TGT) on 2/26/2024 |
NICE NICE | $230.54 -0.4% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $225.00 -> $300.00 | Low | View details for Oppenheimer rating of NICE (NASDAQ:NICE) on 2/23/2024 |
OLED Universal Display | $151.97 -1.3% | 2/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $210.00 -> $200.00 | Low | View details for Oppenheimer rating of Universal Display (NASDAQ:OLED) on 2/23/2024 |
SPXC SPX Technologies | $117.50 -1.1% | 2/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $118.00 -> $124.00 | Low | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 2/23/2024 |
TOL Toll Brothers | $113.42 -0.8% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $141.00 | Low | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 2/23/2024 |
ACA Arcosa | $76.87 -2.7% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $90.00 | Low | View details for Oppenheimer rating of Arcosa (NYSE:ACA) on 2/23/2024 |
ALTR Altair Engineering | $80.56 -0.7% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $100.00 | Low | View details for Oppenheimer rating of Altair Engineering (NASDAQ:ALTR) on 2/23/2024 |
BLDR Builders FirstSource | $179.39 -1.5% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $220.00 -> $242.00 | Low | View details for Oppenheimer rating of Builders FirstSource (NYSE:BLDR) on 2/23/2024 |
CCAP Crescent Capital BDC | $17.00 +0.1% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $19.00 | Low | View details for Oppenheimer rating of Crescent Capital BDC (NASDAQ:CCAP) on 2/23/2024 |
INTU Intuit | $613.21 +0.3% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $678.00 -> $712.00 | Low | View details for Oppenheimer rating of Intuit (NASDAQ:INTU) on 2/23/2024 |
CYH Community Health Systems | $2.91 -0.3% | 2/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $6.50 -> $5.50 | Low | View details for Oppenheimer rating of Community Health Systems (NYSE:CYH) on 2/22/2024 |
DOCN DigitalOcean | $33.23 -0.5% | 2/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $37.00 -> $46.00 | Low | View details for Oppenheimer rating of DigitalOcean (NASDAQ:DOCN) on 2/22/2024 |
NVDA NVIDIA | $840.35 -3.9% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $850.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 2/22/2024 |
ADI Analog Devices | $189.43 -0.9% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $215.00 | Low | View details for Oppenheimer rating of Analog Devices (NASDAQ:ADI) on 2/22/2024 |
JACK Jack in the Box | $58.89 -3.3% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $98.00 | Low | View details for Oppenheimer rating of Jack in the Box (NASDAQ:JACK) on 2/22/2024 |
PNST Pinstripes | $2.98 +1.7% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $6.00 | Low | View details for Oppenheimer rating of Pinstripes (NYSE:PNST) on 2/22/2024 |
CAKE Cheesecake Factory | $33.48 -2.2% | 2/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Cheesecake Factory (NASDAQ:CAKE) on 2/22/2024 |
RUN Sunrun | $10.85 +5.0% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $19.00 | Low | View details for Oppenheimer rating of Sunrun (NASDAQ:RUN) on 2/22/2024 |
CNNE Cannae | $19.43 -1.2% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Cannae (NYSE:CNNE) on 2/22/2024 |
ADSK Autodesk | $214.92 -5.8% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $265.00 | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 2/22/2024 |
GWRE Guidewire Software | $108.28 -0.9% | 2/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $115.00 -> $130.00 | Low | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 2/22/2024 |
VEEV Veeva Systems | $199.18 -0.6% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $225.00 | Low | View details for Oppenheimer rating of Veeva Systems (NYSE:VEEV) on 2/22/2024 |
SKIL Skillsoft | $5.78 +6.1% | 2/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Skillsoft (NASDAQ:SKIL) on 2/22/2024 |
CLH Clean Harbors | $191.78 -1.2% | 2/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $178.00 -> $200.00 | Low | View details for Oppenheimer rating of Clean Harbors (NYSE:CLH) on 2/22/2024 |
DPZ Domino's Pizza | $482.14 -0.9% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $470.00 | Low | View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 2/22/2024 |
NVRO Nevro | $12.29 -3.2% | 2/22/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Nevro (NYSE:NVRO) on 2/22/2024 |
VTYX Ventyx Biosciences | $4.38 -8.0% | 2/21/2024 | Reiterated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 2/21/2024 |
LYV Live Nation Entertainment | $91.82 -0.4% | 2/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $105.00 -> $115.00 | Low | View details for Oppenheimer rating of Live Nation Entertainment (NYSE:LYV) on 2/21/2024 |
MDT Medtronic | $79.08 -0.2% | 2/21/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $89.00 -> $92.00 | Low | View details for Oppenheimer rating of Medtronic (NYSE:MDT) on 2/21/2024 |
PANW Palo Alto Networks | $277.33 +0.8% | 2/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $310.00 -> $305.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 2/21/2024 |
TPH Tri Pointe Homes | $34.50 -1.4% | 2/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $41.00 | Low | View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 2/21/2024 |
B Barnes Group | $33.40 -1.6% | 2/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $43.00 | Low | View details for Oppenheimer rating of Barnes Group (NYSE:B) on 2/20/2024 |
DKNG DraftKings | $42.21 -6.1% | 2/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $60.00 | Low | View details for Oppenheimer rating of DraftKings (NASDAQ:DKNG) on 2/20/2024 |
PRTA Prothena | $21.00 -1.6% | 2/20/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $98.00 -> $80.00 | Low | View details for Oppenheimer rating of Prothena (NASDAQ:PRTA) on 2/20/2024 |